Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 07/14/20
End: 12/21/20
Due: 12/21/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination | NCT05545683 | Centro de Estudios en InfectogĂa Pediatrica | user2@example.com | None | 2022-12-01 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |
| Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial) | NCT04405843 | Centro de Estudios en InfectogĂa Pediatrica | user2@example.com | None | 2020-07-14 | 2020-12-21 | 2021-12-21 | - | - | 2025-07-14 |